Satoshi Shimizu
- Hepatology top 1%
- Hepatocellular Carcinoma Treatment and Prognosis 16
- Hepatitis C virus research 13
- Cancer Research top 2%
- Epidemiology top 2%
- Hepatitis B Virus Studies 12
- Liver Disease Diagnosis and Treatment 10
- Oncology top 5%
- Pancreatic and Hepatic Oncology Research 23
- Molecular Biology top 5%
- Cell death mechanisms and regulation 12
-
- Cholangiocarcinoma and Gallbladder Cancer Studies 18
-
- Gallbladder and Bile Duct Disorders 11
Satoshi Shimizu
130 papers receiving 4.2k citations
Hit Papers
Peers
Comparison fields: 5 of 130
- Hepatology 769
- Cancer Research 712
- Epidemiology 1.2k
- Oncology 838
- Molecular Biology 1.9k
Countries citing papers authored by Satoshi Shimizu
This map shows the geographic impact of Satoshi Shimizu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Satoshi Shimizu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Satoshi Shimizu more than expected).
Fields of papers citing papers by Satoshi Shimizu
This network shows the impact of papers produced by Satoshi Shimizu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Satoshi Shimizu. The network helps show where Satoshi Shimizu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Satoshi Shimizu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 1 | |
| 3 | 2024 | 0 | |
| 4 | 2022 | 11 | |
| 5 | 2022 | 8 | |
| 6 | 2022 | 6 | |
| 7 | 2022 | 6 | |
| 8 | 2021 | 4 | |
| 9 | 2021 | 20 | |
| 10 | 2021 | 3 | |
| 11 | 2021 | 3 | |
| 12 | 2020 | 34 | |
| 13 | 2017 | 11 | |
| 14 | 2016 | 110 | |
| 15 | 2015 | 20 | |
| 16 | 2014 | 12 | |
| 17 | 2013 | 1 | |
| 18 | 2011 | 6 | |
| 19 | 2010 | 26 | |
| 20 | 1990 | 2 |
About Satoshi Shimizu
Satoshi Shimizu is a scholar working on Hepatology, Oncology and Molecular Medicine, having authored 135 papers that have together received 4.3k indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (23 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (18 papers), Hepatocellular Carcinoma Treatment and Prognosis (16 papers), Hepatitis C virus research (13 papers), Cell death mechanisms and regulation (12 papers), Hepatitis B Virus Studies (12 papers), Gallbladder and Bile Duct Disorders (11 papers) and Liver Disease Diagnosis and Treatment (10 papers). The work is most often cited by research in Hepatology (769 citations), Cancer Research (712 citations) and Epidemiology (1.2k citations). Satoshi Shimizu has collaborated with scholars based in Japan, United States and United Kingdom. Frequent co-authors include Yoshihide Tsujimoto, Tetsuo Takehara, Norio Hayashi, Takuya Miyagi, Tomohide Tatsumi, Takahiro Kodama, Hayato Hikita, Atsushi Hosui, Hisashi Ishida and Tatsuya Kanto. Their work appears in journals such as Journal of Biological Chemistry, Circulation and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.